|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right of use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets and deferred costs, net | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Debtor-in-possession financing | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued warranty | ||||||||||||||||||||
| Current maturities of long-term debt, net of debt discounts | ||||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of current maturities | ||||||||||||||||||||
| Noncurrent operating lease liabilities | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Other noncurrent liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities not subject to compromise | ||||||||||||||||||||
| Liabilities subject to compromise | ||||||||||||||||||||
| Total liabilities of debtors | ||||||||||||||||||||
| Series A Preferred Stock, $0.01 par value, 400 shares authorized, 0 and 350 shares issued and outstanding at December 30, 2023 and 2022 respectively; liquidation preference of $475,735 at December 31 202 Stockholders equity | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Common shares, $0.01 par value, 100,000 shares authorized, 50,381 shares issued and 48,766 shares outstanding at December 31, 2025 and 100,000 shares authorized, 48,683 shares issued and 47,609 shares outstanding at December 31, 2024 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost, 1,615 shares at December 31, 2025 and 1,074 shares at December 31, 2024 | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders` deficit of debtors |
Loading...
